Cynthia G. McCormick, M.D., serves as an advisor to Arcion regarding regulatory strategy. Dr. McCormick is President of McCormick Consultation LLC, a consulting company providing regulatory services to the healthcare and pharmaceutical industries. Dr. McCormick was previously Director of the Food and Drug Administration's Division of Anesthetic, Critical Care and Addiction Drug Products (since renamed the Division of Analgesics, Anti-inflammatory and Rheumatology Products). As Head of this Division, she was responsible for providing scientific and regulatory oversight for a large number of investigational and marketed analgesic products, including opioids and drugs for the treatment of neuropathic pain.
Dr. McCormick received her A.B. in chemistry from Bryn Mawr College and her M.D. from the Medical College of Pennsylvania.
"Arcion is lead by seasoned industry executives and scientific innovators."